The European Union has determined that from 2016 breast cancer patients should be
treated in Specialist Breast Units that achieve the minimum standards for the mandatory …

Simple Summary This Propensity Score Matched Analysis aimed to assess the efficacy of
superparamagnetic iron oxide (SPIO) and radioisotope sentinel lymph node biopsy (SNLB) …

Background Sentinel lymph node (SLN) status is pivotal for treatment decision-making in
patients with breast cancer. Superparamagnetic iron oxide nanoparticles (SPIO) have been …

Background The objective of this study is to compare the efficacy of the superparamagnetic
iron oxide (SPIO)-guided and standard techniques for sentinel lymph node (SLN) detection …

Purpose. The aim of the study was, through a single institutional analysis of a large
population of breast cancer patients, to assess the feasibility of and the tolerance to …

Superparamagnetic iron oxide nanoparticles (SPIO) are non-inferior to radioisotope and
blue dye (RI+ BD) for sentinel lymph node (SLN) detection. Previously, 2 mL SPIO …

Background Superparamagnetic iron oxide nanoparticles (SPIO) have been used as a
tracer for sentinel lymph node (SLN) localization in breast cancer, demonstrating …

Backgrounds Traditionally, breast conserving surgery for non-palpable breast cancer is
guided by wire or radioactive seed and radioactive tracer for sentinel lymph node biopsy …

Sentinel lymph node biopsy (SLNB) is a well-established procedure for staging clinically
node-negative early breast cancer (BC). Superparamagnetic iron oxide (SPIO) …

Background: Superparamagnetic iron oxide nanoparticles (SPIO) is a sentinel node tracer
with comparable performance to isotope and blue dye. Most studies have evaluated a 2 ml …